Health Care: Drugs

Prana Biotechnology Ltd (PRAN: NASDAQ)

$2.4 -0.04 | -1.64%
06/22/17 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.40
52 Week High 6.69
52 Week Low 1.52
Avg. Daily Vol. (Mil) 0.35
Beta (3 year) 0.24
Share Related Items
Mkt Cap (Mil) 21.36
Shares Out (Mil) 8.90
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.60
Current Ratio 10.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 200.46
Price/Book 1.07
Price/Cash Flow -3.70
Per Share Data
Earnings -0.65
Sales 0.01
Book Value 2.24
Cash Flow -0.65
Business Summary
Prana Biotechnology Ltd is engaged in the development of therapeutic drugs designed to treat the causes of degeneration of the brain as the aging process progresses including Alzheimer's disease, Huntington's disease and Parkinson's disease.
General Information
369 Royal Parade
Level 2
Parkville, VI 3052
Industry : Drugs
Sector: Health Care
Employees: 12
CEO: Geoffrey P. Kempler
Short Interest
Current Month (Mil) 0.19
Previous Month (Mil) 0.21
Short Interest Ratio (Days) 3.90
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PRAN

Latest PRAN Headlines from TheStreet

More Financial News for PRAN

Press Releases for PRAN

See All Press Releases

Partner Headlines for PRAN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter